Pịa ebe a ma ọ bụrụ na nke a bụ ntọhapụ mgbasa ozi gị!

Losartan Ọgwụ Ọbara Ọbara dị elu echetara ugbu a

Mint Pharmaceuticals Inc. na-echetakwa ọtụtụ mbadamba ọgwụ losartan ndenye ya, na 50 mg na 100 mg ike, mgbe ulechara chọpụta adịghị ọcha azido (5- (4- (5-azidomethyl) -2-butyl-4-chloro. -1H imidazol-1-yl)methyl)-[1,1′-biphenyl] -2-yl)-1H tetrazole) n'elu oke anabatara. Ikpughe ogologo oge na adịghị ọcha na ọkwa dị elu karịa ihe e chere na ọ dị mma nwere ike ịbawanye ohere nke ọrịa cancer.

Print Friendly, PDF & Email

Biko hụ ndụmọdụ zuru ezu maka ozi ndị ọzọ, gụnyere ihe ndị Canada kwesịrị ime yana ọrụ Health Canada iji dozie okwu adịghị ọcha azido dị na ọgwụ ụfọdụ.

ProductCompanyDINLotMmebi
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETSAkụkọ ihe mere eme nke Mint Pharmaceuticals Inc.023896572005006959April 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETSAkụkọ ihe mere eme nke Mint Pharmaceuticals Inc.023896572005006960April 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETSAkụkọ ihe mere eme nke Mint Pharmaceuticals Inc.023896572005006961April 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETSAkụkọ ihe mere eme nke Mint Pharmaceuticals Inc.023896572005006962April 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETSAkụkọ ihe mere eme nke Mint Pharmaceuticals Inc.023896572005006963April 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETSAkụkọ ihe mere eme nke Mint Pharmaceuticals Inc.023896572005011154June 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETSAkụkọ ihe mere eme nke Mint Pharmaceuticals Inc.023896572005011156June 2023
MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETSAkụkọ ihe mere eme nke Mint Pharmaceuticals Inc.023896652005006807April 2022
MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETSAkụkọ ihe mere eme nke Mint Pharmaceuticals Inc.023896652005006808April 2022
MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETSAkụkọ ihe mere eme nke Mint Pharmaceuticals Inc.023896652005006809April 2022
MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETSAkụkọ ihe mere eme nke Mint Pharmaceuticals Inc.023896652005006810April 2022
MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETS Akụkọ ihe mere eme nke Mint Pharmaceuticals Inc.023896652105002149December 2022
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSAkụkọ ihe mere eme nke Mint Pharmaceuticals Inc.023896731805012687October 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSAkụkọ ihe mere eme nke Mint Pharmaceuticals Inc.023896731805012688October 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSAkụkọ ihe mere eme nke Mint Pharmaceuticals Inc.023896731805012689October 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSAkụkọ ihe mere eme nke Mint Pharmaceuticals Inc.023896731805012792October 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSAkụkọ ihe mere eme nke Mint Pharmaceuticals Inc.023896731905001010December 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETS Akụkọ ihe mere eme nke Mint Pharmaceuticals Inc.023896731905001011December 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSAkụkọ ihe mere eme nke Mint Pharmaceuticals Inc.023896732005006947April 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSAkụkọ ihe mere eme nke Mint Pharmaceuticals Inc.023896732005006949April 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSAkụkọ ihe mere eme nke Mint Pharmaceuticals Inc.023896732005006950April 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSAkụkọ ihe mere eme nke Mint Pharmaceuticals Inc.023896732005006951April 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETS Akụkọ ihe mere eme nke Mint Pharmaceuticals Inc.023896732005007297April 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSAkụkọ ihe mere eme nke Mint Pharmaceuticals Inc.023896732005007298April 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSAkụkọ ihe mere eme nke Mint Pharmaceuticals Inc.023896732005013776August 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSAkụkọ ihe mere eme nke Mint Pharmaceuticals Inc.023896732105002150December 2023
Print Friendly, PDF & Email

Banyere chepụtara

nchịkọta akụkọ

Onye nchịkọta akụkọ bụ Linda Hohnholz.

Ahapụ a Comment